Enterprise AIConfidence BUnited Statesactive

PathAI

AI pathology company developing diagnostic and life-science workflow products.

Official websitepathai.com
RegionBoston, United States
CategoryEnterprise AI
Funding statusSeries C · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
May 18, 2021Confidence A
Product0 evidence links

PathAI product scope reviewed

PathAI public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
May 18, 2021Confidence A
Funding0 evidence links

PathAI capital or status signal reviewed

PathAI public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
May 18, 2021

Series C

AmountUndisclosed
InvestorsD1 Capital Partners, Kaiser Permanente
EvidenceConfidence A
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

PathAI capital or status signal

PathAI · official
Confidence A

PathAI public capital or strategic-status source reviewed for stage and timeline signal.

Trust APublic review
Open source

PathAI official product profile

PathAI official site · official
Confidence A

PathAI official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Similar projects

Same category or overlapping tags